Jaguar Health, Inc. License Agreements
9 Contracts & Agreements
- First Amendment to Amended and Restated License Agreement, dated March 16, 2024, by and between Napo Pharmaceuticals, Inc. and Nano Therapeutics S.p.A (Filed With SEC on May 14, 2024)
- Amended and Restated License and Services Agreement, dated October 11, 2022, by and among Jaguar Health, Inc., SynWorld Technologies Corporation, C&E Telecom, LTD and Tao Wang (Filed With SEC on October 14, 2022)
- First Amendment to the License and Services Agreement, dated August 18, 2022, by and between Jaguar Health, Inc. and SynWorld Technologies Corporation (Filed With SEC on August 23, 2022)
- Amended and Restated License Agreement, dated July 19, 2022, by and between Napo Pharmaceuticals, Inc. and Napo Therapeutics S.p.A (Filed With SEC on July 20, 2022)
- License and Services Agreement, dated June 29 2022, by and among Jaguar Health, Inc., SynWorld Technologies Corporation, C&E Telecom, LTD and Tao Wang (Filed With SEC on June 29, 2022)
- License Agreement, dated August 18, 2021, by and between Napo Pharmaceuticals, Inc. and Napo EU S.p.A (Filed With SEC on August 24, 2021)
- License Agreement, dated April 15, 2020, by and between Jaguar Health, Inc. and Atlas Sciences, LLC (Filed With SEC on April 16, 2020)
- *** TEXT OMITTED AND SUBMITTED PURSUANT TO CONFIDENTIAL TREATMENT REQUEST LICENSE, DEVELOPMENT, CO-PROMOTION AND COMMERCIALIZATION AGREEMENT BY AND BETWEEN JAGUAR ANIMAL HEALTH,... (Filed With SEC on February 15, 2017)
- AMENDMENT NO. 1 TO AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on March 20, 2015)
